PEAK6 Investments’s Co-Diagnostics CODX Stock Holding History

PEAK6 Investments’s Portfolio CODX Stock Details CODX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-660	Closed	-$24.8K	–	3575
2024 Q2	$24.8K	Buy	+660	New	+$24K	﹤0.01%	3244

Other funds holding CODX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

KAS

Kestra Advisory Services Austin, Texas $26.4B AUM 21.05% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

KOC

Koss-Olinger Consulting Gainesville, Florida $1.19B AUM 15.91% 1-Year Est. Return

PEAK6 Investments's CODX Position: Q3 2024 in Review

PEAK6 Investments sold out of Co-Diagnostics (CODX) in Q3 2024, closing a stake of 660 shares — an estimated $24.8K sold.

PEAK6 Investments first reported a position in CODX in Q2 2024 and held it in 1 quarter. The position peaked at $24.8K in Q2 2024. 36 funds tracked by Wall St. Rank hold CODX as of Q3 2024.

PEAK6 Investments reported no remaining Co-Diagnostics position as of Q3 2024 after selling out during the quarter.
PEAK6 Investments sold 660 Co-Diagnostics shares in Q3 2024, an estimated $24.8K.
PEAK6 Investments first reported a position in Co-Diagnostics in Q2 2024 and held it in 1 quarter.
PEAK6 Investments's Co-Diagnostics position peaked at $24.8K in Q2 2024.
36 funds tracked by Wall St. Rank held Co-Diagnostics as of Q3 2024.

Based on PEAK6 Investments's 13F filing for Q3 2024, filed 14 Nov 2024.